Ran Nussbaum Insider Trading $PRVL Prevail Therapeutics Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Ran Nussbaum.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Ran Nussbaum. Ran Nussbaum is Director in ARQULE INC ($ARQL) and in Eloxx Pharmaceuticals, Inc. ($ELOX) and Director in Eloxx Pharmaceuticals, Inc. ($ELOX) and Director in Kite Pharma, Inc. ($KITE) and Director in Keros Therapeutics, Inc. ($KROS) and Director in UroGen Pharma Ltd. ($URGN) and Director in Prevail Therapeutics Inc. ($PRVL).
Ran Nussbaum in Prevail Therapeutics Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Ran Nussbaum: Director
Holdings: 0 shares
Latest Transaction: Jan 26 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Ran Nussbaum in Prevail Therapeutics Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ARQL, ELOX, KROS, KITE, PRVL, URGN
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 26 2021 | PRVL | Prevail Therapeuti ... | Nussbaum Ran | Director | Option Exercise | D | 16.98 | 17,000 | 288,660 | 0 | |
| Jan 26 2021 | PRVL | Prevail Therapeuti ... | Nussbaum Ran | Director | Sell | U | 0.00 | 1,576,881 | 0 | 0 | 1.6 M to 0 (-100.00 %) |
| Jun 19 2020 | PRVL | Prevail Therapeuti ... | Nussbaum Ran | Director | Option Exercise | A | 16.98 | 17,000 | 288,660 | 17,000 |
Page: 1